Evidence map›Paper›PMID 39622052›Full record

ArticleACS biomaterials science & engineering2025

FRESH 3D Bioprinting of Collagen Types I, II, and III.

Samuel P Moss, Daniel J Shiwarski, Adam W Feinberg

Abstract read
In one paragraph

Article in ACS biomaterials science & engineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Suspended Tissue Engineering with Assemblable Microfluidics (STEAM).bioRxiv : the preprint server for biology · 2025
    Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Samuel P MossDepartment of Biomedical Engineering, Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, United States of America.ORCID 0000-0002-8471-5489
Daniel J ShiwarskiDepartment of Biomedical Engineering, Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, United States of America.ORCID 0000-0001-6978-303X
Adam W FeinbergDepartment of Biomedical Engineering, Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, United States of America.ORCID 0000-0003-3338-5456

Funding

Bioengineering Cornea with Autologous Stem CellsR01EY024642 · NEI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Yiqin Du, Adam Walter Feinberg · 2016 to 2026
$4.1M
Development of a Collagen-based 3D Bioprinted Microfluidic Platform for Vascular Tissue Engineering and Disease ModelingR00HL155777 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SHIWARSKI, DANIEL J · 2023 to 2025
$747k
Development of a Collagen-based 3D Bioprinted Microfluidic Platform for Vascular Tissue Engineering and Disease ModelingK99HL155777 · NHLBI · CARNEGIE-MELLON UNIVERSITY · PI SHIWARSKI, DANIEL J · 2021 to 2022
$222k
NEI NIH HHS R01 EY024642NHLBI NIH HHS K99 HL155777NHLBI NIH HHS R00 HL155777
6 · The paper itself

Abstract

Collagens play a vital role in the mechanical integrity of tissues as well as in physical and chemical signaling throughout the body. As such, collagens are widely used biomaterials in tissue engineering; however, most 3D fabrication methods use only collagen type I and are restricted to simple cast or molded geometries that are not representative of native tissue. Freeform reversible embedding of suspended hydrogel (FRESH) 3D bioprinting has emerged as a method to fabricate complex 3D scaffolds from collagen I but has yet to be leveraged for other collagen isoforms. Here, we developed collagen type II, collagen type III, and combination bioinks for FRESH 3D bioprinting of millimeter-sized scaffolds with micrometer scale features with fidelity comparable to scaffolds fabricated with the established collagen I bioink. At the microscale, single filament extrusions were similar across all collagen bioinks with a nominal diameter of ∼100 μm using a 34-gauge needle. Scaffolds as large as 10 × 10 × 2 mm were also fabricated and showed similar overall resolution and fidelity across collagen bioinks. Finally, cell adhesion and growth on the different collagen bioinks as either cast or FRESH 3D bioprinted scaffolds were compared and found to support similar growth behaviors. In total, our results expand the range of collagen isoform bioinks that can be 3D bioprinted and demonstrate that collagen types I, II, III, and combinations thereof can all be FRESH printed with high fidelity and comparable biological response. This serves to expand the toolkit for the fabrication of tailored collagen scaffolds that can better recapitulate the extracellular matrix properties of specific tissue types.

Indexed as

BioprintingCollagen Type ICollagen Type IICollagen Type IIIPrinting, Three-DimensionalTissue ScaffoldsAnimalsBiocompatible MaterialsCell AdhesionHumansHydrogelsMiceTissue EngineeringBiocompatible MaterialsCollagen Type ICollagen Type IICollagen Type IIIHydrogels3D printingbioprintingcollagenFRESHscaffoldstissue engineering

Identifiers

PMID39622052
PMCPMC11733922

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.